Indeed, Liu et al. showed that inhibition of PARP activity can sensitize hypoxic cancer cells and the combination of ionizing radiation-PARP inhibition has the potential to improve the therapeutic benefit of radiotherapy [15]. The gene discussed is PARP1; the disease is cancer.